Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this trial is to evaluate the safety and efficacy orally administered CG5503 PR tablets BID over 4 weeks (Maintenance phase) in subjects with moderate to severe chronic malignant tumor-related pain in comparison with placebo.
Inclusion criteria
- The treatment of chronic tumor-related pain